Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Asset Writedowns and Impairment (2024 - 2025)

Glaukos (GKOS) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $310000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $310000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $7.4 million for FY2025, 67.7% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $310000.0 at Glaukos, down from $3.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $3.0 million in Q3 2025, with the low at -$248000.0 in Q2 2024.